Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

said Flemming Nielsen, President, Octapharma USA. "By simplifying preparation and expanding dosing flexibility, we're helping providers act faster and more precisely – when every second counts." Fibryga® is the first and only virus-inactivated,...

Ark Biopharmaceutical Granted China Marketing Authorization for Aizhida in ADHD Treatment

The approval of Aizhida provides clinicians with a new therapeutic tool. We anticipate its real-world application will help improve the treatment landscape for ADHD patients in China, offering new hope particularly for those with suboptimal...

Novotech Appoints Anand Tharmaratnam as Chief Executive Officer

global and complex biotech programs. Novotech will continue to deliver impactful and innovative outcomes for clients to help advance future medicines.” About Novotech Novotech is a globally recognized full-service clinical research organization...

Sapio Sciences Collaborates with the Wellcome Sanger Institute on Transforming Digital Laboratories

continue shaping the future of genomic science,” said Mike Hampton, Chief Commercial Officer at Sapio Sciences. “Sanger helped set the standard for large-scale genomics, and they have very clear expectations for their scientific enablement. With...

GMA with MOVIVA®: Setting New Standards in Endoscopic Bariatric Treatment.

expanding across Europe. With around 80 procedures performed within a short timeframe in eight countries, MOVIVA® is helping to establish a new era of endoscopic bariatric treatment – offering a less invasive option as obesity rates continue to...

Menarini Group Shares New Data on ELZONRIS® (tagraxofusp-erzs)

important role in both monotherapy and combination settings for the treatment of BPDCN, and that it also has potential to help patients living with other aggressive hematologic malignancies, where more effective treatment options are desperately...

VahatiCor Closes Oversubscribed Series B Financing to Speed Up A-FLUX® Development for Coronary Microvascular Dysfunction

(CMD), a condition that can cause chest pressure, heaviness, and discomfort. Through this advancement, VahatiCor is helping broaden access to care for individuals who have long faced limited treatment alternatives. About S3 Ventures Founded in...

Emulate, in Partnership with FUJIFILM Cellular Dynamics, Launches Brain-Chip R1 to Advance Neurological Drug Development

cells including Emulate’s proprietary BMECs, and Brain-Chip media. This integrated offering simplifies implementation, helping researchers rapidly advance their CNS studies with enhanced human relevance. The Brain-Chip R1 is compatible with...

Jazz Pharmaceuticals presents new clinical and translational data for Modeyso™ (dordaviprone) in H3 K27M-mutant diffuse midline glioma at SNO 2025

molecular pathways associated with sensitivity to dordaviprone and exploring how targeted combination strategies may help to enhance response. \Preclinical data evaluating how dordaviprone may influence the tumor immune environment to inform future...

The BioTech Breakthrough Award has been granted to Asahi Kasei for the Planova™ FG1 Filter

Head of Asahi Kasei Bioprocess. “Planova™ FG1 represents decades of filtration expertise and our continued commitment to helping manufacturers achieve higher efficiency without compromising safety.” With a water flux of 1,220 liters per square...

Odyssey Therapeutics Welcomes Dennis Dean, Ph.D., as EVP, Non-Clinical Development

discovery through IND* and into the clinic, Dennis is uniquely positioned to strengthen our non-clinical capabilities and help accelerate transformative medicines for patients.” Dr. Dean brings more than 25 years of experience spanning...

Gilead’s Livdelzi® Shows Sustained Efficacy in PBC, Reducing ALP, Relieving Itch, and Potentially Slowing Disease Progression

benefit observed in those at highest risk. This reinforces our belief in Livdelzi’s treatment profile and its potential to help transform care for people living with PBC. At Gilead, we remain focused on delivering innovation that drives long-term...

PRM Pharma Launches HemiClor® 12.5 mg, the First FDA-Approved Low-Dose Chlorthalidone Tablet for Hypertension

now available in pharmacies nationwide. Pharmacy Savings Programs, such as SaveHealth, GoodRx, SingleCare, and WellRx, may help provide important savings to eligible patients. Using SaveHealth, for example, patients may be able to purchase a 30-day...

Serenity Mental Health Centers: Where to Get TMS Therapy in Colorado Springs

they need hope,” said Tricia Pease, COO and co-founder. “Serenity’s call center staff is ready and available to help patients get the care they need, and fast.” Serenity’s outpatient model includes flexible scheduling and same-day appointments,...

Merz Aesthetics® Introduces New BELOTERO® Syringe, Offering Greater Precision, Comfort, and Ease of Use.

long history of empowering health care professionals, patients, and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically...

Fresenius Kabi’s biosimilars Conexxence® and Bomyntra® (denosumab-bnht) receive interchangeable designation from the FDA

supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a...

During FII Week in Riyadh, Rubedo Life Sciences and SVAX announce a strategic partnership

ongoing challenge in the standard of care worldwide. Incorporating study sites at the crossroads of three continents will help provide a more representative overall patient population for the evaluation of RLS-1496 in this important condition.” “At...

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body’s immune system to help detect and fight tumor cells. KEYTRUDA is a humanized monoclonal antibody that blocks the interaction between PD-1 and...

To drive global expansion of digital chemistry and discovery, Chemify raises over $50 million in an oversubscribed Series B round

Chemputation—Chemify’s purpose-built AI to digitize molecule creation—has raised over $50 million in Series B funding to help accelerate its mission of becoming the global leader in digital chemistry, molecular design and manufacturing. The...

Illumina's Constellation Mapped Read technology uncovers hard-to-see genomic insights in the GeneDx pilot

delays and increase the risk of some childhood cancers. Deep and rapid insights from whole-genome sequencing can help researchers understand and better identify potential treatments for these hard-to-diagnose conditions. Constellation is emerging...